top of page
Executive Spotlights

Beacon Therapeutics Secures $170M in Series B Funding to Accelerate Progress in Ophthalmic Gene Therapy Development

London and Cambridge, MA, July 3, 2024 (PRNewswire) -- Beacon Therapeutics has raised $170 million in Series B funding to advance its ophthalmic gene therapy initiatives, supported by Forbion and other investors. The funding will expedite development of AGTC-501 and other pipeline projects, while new appointments strengthen the company's board governance.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial

Rober A. Michael takes the helm as CEO of AbbVie

North Chicago, IL, July 1, 2024 (PRNewswire) -- AbbVie has named Robert A. Michael as its new CEO and board member, effective. He takes over from Richard A. Gonzalez, who now serves as executive cha


Life Science Headlines
bottom of page